Cogent Biosciences, Inc. COGT

32.31 0.88 2.80% as of 25 Sep
Market cap
$5.5B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

390.89 900.77 866.38 792.30
Total current assets
397.24 910.36 877.80 804.82
Property, Plant, Equpment (Net)
5.27 5.46 5.30 4.78
Long-term assets (Other)
4.82 3.72 2.36 2.36
Total non-current assets
28.69 27.25 25.20 29.73
Total Assets
425.93 937.61 903.01 834.55
Accounts Payable
16.03 9.50 13.74 7.49
Accrued Expenses
44.51 52.90 42.85 50.32
Total current liabilities
62.25 63.95 57.98 59.30
Long Term Debt (Total)
44.25 222.90 223.17 223.46
Non-current Liabilities (Other)
2.37 0.03 0.06 0.09
Total non-current liabilities
61.22 237.28 237.33 242.86
Total liabilities
123.47 301.24 295.31 302.16
Additional Paid In Capital
1,280.13 1,734.88 1,828.96 1,850.41
Preferred Stock (Total)
107.92 89.39 64.75 64.75
Common Stock (Net)
0.14 0.16 0.17 0.17
Retained Earnings
(1,085.93) (1,188.42) (1,285.77) (1,382.18)
Common Equity (Total)
194.55 546.98 542.94 467.64
Shareholders Equity (Total)
302.46 636.37 607.69 532.39
Shareholders Equity and Liabilities (Total)
425.93 937.61 903.01 834.55
Shares (Common)
139.83 160.98 170.77 171.60
Shares (Preferred)
0.08 0.07 0.04 0.04
Shareholders Equity (Tangible)
302.46 636.37 607.69 532.39
Net Debt
(346.64) (677.87) (643.20) (568.84)
Total Debt
44.25 222.90 223.17 223.46

Fold the line items

In millions of $ except per-share values · columns are period end dates